ARCHIVES

Senate Committee Adds $100 Million for Cancer, Earmarks Extra Positions for NCI, Backs New Construction

This article is from The Cancer Letter archive.

Vol. 01 No. 38 | September 19, 1975

Download PDF Visit The Full Archive

Related Articles

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid

March 14, 1986

DCE Board Okays New Melanoma Study, Other Concepts

November 11, 1988

Senate Outlines Budget Priorities In Bill Report

July 19, 1991

U.S. Adults close to Eating “5 A Day” Of Fruits, Vegetables

March 28, 1997

Letter: Medicare Policy May Delay Access to Cancer Drugs

June 13, 2003